Letters Drug eluting stents

What fuels public policy?

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39150.648762.BE (Published 22 March 2007) Cite this as: BMJ 2007;334:599

This article has a correction. Please see:

  1. Mark H Wilson, director of medical ethics health (research@sympatico.ca)
  1. Health Research Associates, Ottawa, Canada K2B 6J4

    Around 60-75% of the millions of drug eluting stents inserted globally are not licensed.1 What has fuelled the high unlicensed use of a device associated with thrombosis? This question was not dealt with by the Food and Drug Administration panel or recent articles on such stents.2 …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription